Hughes Steven George bought RNA
August 6, 2025 · Form 4 insider transaction
Hughes Steven George bought 6,167 shares of Atrium Therapeutics, Inc. at $22.47 per share, a transaction worth $138.6K. The trade was recorded as option exercise under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
6,167
Price
$22.47
Total value
$138.6K
InsiderHughes Steven George
RoleOfficer
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateAugust 6, 2025
Filing dateAugust 8, 2025
Shares owned after79,017
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on June 12, 2024.